A good illustration is epidermal growth factor receptor (EGFR)/anaplastic lymphoma kinase (ALK) in lung cancer [10], CD19 in diffuse large B cell lymphoma [11] and HER2 in breast cancer [12]. This evidence concerns the gene ALK and breast carcinoma.